Literature DB >> 7114042

A case-control study of cancer of the endometrium.

J L Kelsey, V A LiVolsi, T R Holford, D B Fischer, E D Mostow, P E Schwartz, T O'Connor, C White.   

Abstract

A hospital-based case-control study of the epidemiology of endometrial cancer in women aged 45-74 years was carried out in Connecticut from 1977 to 1979. In total, 167 cases and 903 controls were included. Elevated risks were associated with the following factors: overweight, nulliparity, few pregnancies, use of estrogen replacement therapy, older age at menopause, and a history of ovarian or endometrial cancer in mother or a sister. Whites were more frequently affected than blacks, and better-educated women more often than less-educated women. Use of oral contraceptives was associated with a decreased risk, although the decrease did not reach statistical significance.

Entities:  

Keywords:  Age Factors; Americas; Biology; Body Weight; Cancer; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Methods--side effects; Cultural Background; Data Analysis; Demographic Factors; Developed Countries; Diseases; Endocrine System; Endometrial Cancer; Estrogens; Ethnic Groups; Family Planning; Fertility; Fertility Measurements; Hormones; Linear Regression; Menopause; Neoplasms; North America; Northern America; Nulliparity; Obesity; Oral Contraceptives--side effects; Parity; Physiology; Population; Population At Risk; Population Characteristics; Population Dynamics; Reproduction; Reproductive Control Agents; Research Methodology; Statistical Regression; United States; Whites

Mesh:

Substances:

Year:  1982        PMID: 7114042     DOI: 10.1093/oxfordjournals.aje.a113417

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  38 in total

Review 1.  Induced abortion as cancer risk factor: a review of epidemiological evidence.

Authors:  L I Remennick
Journal:  J Epidemiol Community Health       Date:  1990-12       Impact factor: 3.710

Review 2.  [The role of progestins].

Authors:  H I Wyss
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

3.  Oral contraceptives and the risk of endometrial cancer.

Authors:  F Levi; C La Vecchia; C Gulie; E Negri; V Monnier; S Franceschi; J F Delaloye; P De Grandi
Journal:  Cancer Causes Control       Date:  1991-03       Impact factor: 2.506

Review 4.  Exogenous hormones in the aetiology of cancer in women.

Authors:  M P Vessey
Journal:  J R Soc Med       Date:  1984-07       Impact factor: 5.344

5.  Diabetes mellitus and risk of endometrial cancer: a meta-analysis.

Authors:  E Friberg; N Orsini; C S Mantzoros; A Wolk
Journal:  Diabetologia       Date:  2007-05-03       Impact factor: 10.122

6.  The use of steroid sulfatase inhibitors as a novel therapeutic strategy against hormone-dependent endometrial cancer.

Authors:  Paul A Foster; L W Lawrence Woo; Barry V L Potter; Michael J Reed; Atul Purohit
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

7.  Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer.

Authors:  Akila N Viswanathan; Diane Feskanich; Eva S Schernhammer; Susan E Hankinson
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

Review 8.  Genetic polymorphisms and endometrial cancer risk.

Authors:  Larissa A Meyer; Shannon N Westin; Karen H Lu; Michael R Milam
Journal:  Expert Rev Anticancer Ther       Date:  2008-07       Impact factor: 4.512

9.  Novel hydroxysteroid (17beta) dehydrogenase 1 inhibitors reverse estrogen-induced endometrial hyperplasia in transgenic mice.

Authors:  Taija Saloniemi; Päivi Järvensivu; Pasi Koskimies; Heli Jokela; Tarja Lamminen; Sadaf Ghaem-Maghami; Roberto Dina; Pauliina Damdimopoulou; Sari Mäkelä; Antti Perheentupa; Harry Kujari; Jan Brosens; Matti Poutanen
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

10.  Lactation and cancer risk: is there a relation specific to breast cancer?

Authors:  G Kvåle; I Heuch
Journal:  J Epidemiol Community Health       Date:  1988-03       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.